LF
RMD icon

Lansforsakringar Fondforvaltning’s ResMed RMD Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.1M Buy
36,453
+32,100
+737% +$6.65M 0.03% 378
2026
Q1 		$977K Sell
4,353
-330
-7% -$82.2K 0.01% 504
2025
Q4 		$1.13M Buy
4,683
+777
+20% +$199K 0.01% 513
2025
Q3 		$1.07M Sell
3,906
-780
-17% -$213K 0.01% 503
2025
Q2 		$1.21M Buy
4,686
+953
+26% +$227K 0.01% 502
2025
Q1 		$836K Buy
3,733
+2,031
+119% +$474K 0.01% 524
2024
Q4 		$389K Buy
+1,702
New +$410K ﹤0.01% 535

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lansforsakringar Fondforvaltning's RMD Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning increased its ResMed (RMD) stake by 737% in Q2 2026, buying an estimated $6.65M and bringing the position to 36,453 shares worth $7.1M. The position accounts for 0.03% of the portfolio, ranked #378.

Lansforsakringar Fondforvaltning first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 36,453 shares of ResMed worth $7.1M as of Q2 2026.
  • Lansforsakringar Fondforvaltning bought 32,100 ResMed shares in Q2 2026, an estimated $6.65M.
  • ResMed made up 0.03% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #378 holding.
  • Lansforsakringar Fondforvaltning first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.